Zobrazeno 1 - 10
of 2 840
pro vyhledávání: '"Perioperative Chemotherapy"'
Autor:
S. Takei, A. Kawazoe, A. Jubashi, M. Komatsu, K. Sato, S. Mishima, D. Kotani, M. Yura, N. Sakamoto, S. Sakashita, T. Kuwata, T. Kojima, T. Fujita, T. Kinoshita, K. Shitara
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 4, Iss , Pp 100050- (2024)
Background: Although the common treatment strategy for localized gastric cancer in Japan is gastrectomy followed by adjuvant chemotherapy, several randomized studies in non-Japanese populations have established perioperative chemotherapy as the stand
Externí odkaz:
https://doaj.org/article/fbe485f1762740a6b0142e7e0fcfe368
Autor:
Kristian Egebjerg, Tobias Sørup Andersen, Lene Bæksgaard, Rajendra Garbyal, Mette Siemsen, Michael Achiam, Paul Morten Mau-Sørensen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: Perioperative 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) is recommended in resectable esophagogastric adenocarcinoma based on randomised trials. However, the effectiveness of FLOT in routine clinical practice remains
Externí odkaz:
https://doaj.org/article/d493e06ff6014eb2b37c936043b47467
Autor:
Masanori Tokunaga, Yukinori Kurokawa, Takeo Fukagawa, Kei Muro, Kohei Shitara, Yasuhiro Kodera, Masanori Terashima
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 6, Pp 856-862 (2023)
Abstract Treatment strategy for locally advanced gastric cancer differs worldwide. Neoadjuvant chemotherapy (NAC) is considered one of the promising treatment options for locally advanced gastric cancer, even in Japan, and clinical trials have been c
Externí odkaz:
https://doaj.org/article/76d971897a834da9bc36ccc691af5e58
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 17, Pp 3523-3536 (2023)
Jie Wang,1,* Lei Deng,2,* Zihao Ding,3,* Yaosheng Zhang,3 Yao Zhang,1 Kangpeng Li,1 Changsong Zhao,1 Qiang Zhang1 1Department of Orthopedics, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of Chin
Externí odkaz:
https://doaj.org/article/df61ba282f1f44a796932c09ac2a6f31
Autor:
Pengfei Su, Lin Jiang, Yingjing Zhang, Tian Yu, Hongyun Huang, Moxi Chen, Can Cao, Weiming Kang, Yuqin Liu, Jianchun Yu
Publikováno v:
European Journal of Medical Research, Vol 28, Iss 1, Pp 1-9 (2023)
Abstract Background Neoadjuvant chemotherapy (NAC) is increasingly used in locally advanced gastric cancer (LAGC), but the clinical safety and efficacy are still controversial. This study aims to compare perioperative chemotherapy (PEC) with adjuvant
Externí odkaz:
https://doaj.org/article/798e91dfc71844fda679cddfdd53c4f7
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 4, Pp 565-571 (2023)
Abstract Biliary tract cancer (BTCs) is a heterogeneous malignancy divided into cholangiocarcinoma, gallbladder cancer, and ampullary cancer. Due to little or no symptoms, most patients with BTCs are diagnosed with unresectable or metastatic disease.
Externí odkaz:
https://doaj.org/article/cb39ddc8a93542da9268d6b4afe3ba10
Autor:
V. Pusceddu, C. Donisi, A. Pretta, F. Loi, R. Badas, P. Ziranu, M. Puzzoni, E. Lai, S. Mariani, E. Palmas, M. Pozzari, E. Cimbro, A.P. D’Agata, S. Pinto, F. Coghe, S. Bergamini, D. Fanni, G. Faa, T. Yoshino, M. Scartozzi
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 3, Iss , Pp 100036- (2024)
The ‘immune pattern’ of the esophagogastric junction and gastric cancer (GC) has been related to tumour progression and/or response to therapies. GC can be classified as immunogenic or immune-resistant based on the infiltration of the tumour micr
Externí odkaz:
https://doaj.org/article/2ab347a217804cdf9c5446add8a420b7
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-28 (2023)
Abstract Gastric cancer (GC) is one of the most common malignancies worldwide. Most patients are diagnosed at advanced stages due to the subtle symptoms of earlier disease and the low rate of regular screening. Systemic therapies for GC, including ch
Externí odkaz:
https://doaj.org/article/e0932f6266d844bc9e8465e44cb996d4
Autor:
Yuehong Cui, Yiyi Yu, Song Zheng, Jie’er Ying, Yi’an Du, Yan Wang, Xuefei Wang, Zhenbin Shen, Fenglin Liu, Minzhi Lv, Yihong Sun, Tianshu Liu
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The Neo-REGATTA study evaluated the effectiveness and safety of Docetaxel, oxaliplatin, and S-1 (DOS regimen) followed by radical resection vs. chemotherapy in advanced gastric adenocarcinoma patients with single non-curable facto
Externí odkaz:
https://doaj.org/article/20b8cb8643054d398233d66b42c47066
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 6, Pp 164-169 (2023)
Background. Gastric cancer is the 5th most common cancer and the 3rd leading cause of cancer death globally. In Russia, gastric cancer is the 2-nd leading cause of death (10.7 %). Surgery in combination with perioperative/adjuvant chemotherapy is the
Externí odkaz:
https://doaj.org/article/03836cccc4a54d439514afd374b1264b